ESTRELLA IMMUNOPHARMA, INC. Treasury Stock, Common, Shares
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Treasury Stock, Common, Shares of 515.28 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-08-13
- 2026-06-30: Treasury Stock, Common, Shares 515.28K shares.
- 2026-03-31: Treasury Stock, Common, Shares 515.28K shares.
- 2025-12-31: Treasury Stock, Common, Shares 515.28K shares.
- 2025-09-30: Treasury Stock, Common, Shares 515.28K shares.
| Period end | Treasury Stock, Common, Shares |
|---|---|
| 2026-06-30 | 515.28K shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 515.28K shares 10-Q · filed 2026-05-18 |
| 2025-12-31 | 515.28K shares 10-Q · filed 2026-08-13 |
| 2025-09-30 | 515.28K shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 515.28K shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 515.28K shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 486.98K shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 431.72K shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 321.79K shares 10-KT · filed 2025-03-25 |
| 2024-03-31 | 74.89K shares 10-Q · filed 2024-05-15 |
| 2023-06-30 | 0.00 shares 10-K · filed 2024-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |